Today on DrugResearcher.com   Mixed results dampen expectations for Eli Lilly's prasugrel Pretender to Avastin throne poised to enter clinical trails EU considers Afghan poppy pilot Sigma-Aldrich halves miRNA preparation times Pharma must 'reinvent' itself to survive

Related Industry News   Flutiform safety results a 'significant milestone' FDA failure on foreign inspections frightening Japan's Tamiflu supply halved Neural stem cell drug delivery is encapsulating

Breaking News on Drug Discovery
Daily  Monday 05 November 2007		Forward to a colleague

	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here Access Full Stories Mixed results dampen expectations for Eli Lilly's prasugrel When it comes to choosing between anti-blood clot medicines, clinicians could be stuck between a rock and a hard place following mixed trial results for Eli Lilly's prasugrel... Read Pretender to Avastin throne poised to enter clinical trails BioInvent and ThromboGenics' new anticancer antibody is poised to enter clinical trials and could prove a serious rival to VEGF-blocking drugs, due to fewer side-effects and less drug resistance... Read EU considers Afghan poppy pilot A proposed pilot programme to divert Afghanistan's infamous and illegal opium supply for legal use in analgesics has been backed by the European Parliament but is facing fierce criticism elsewhere... Read Sigma-Aldrich halves miRNA preparation times Sigma-Aldrich has continued its push into the RNAi field with the launch of its new mirPremier miRNA (microRNA) isolation kit that promises to speed up miRNA preparation while removing all large, unwanted RNA... Read Pharma must 'reinvent' itself to survive With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent... Read
	All News Headlines for: November | October | September
	Product Presentation ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here
	Related Industry News Flutiform safety results a 'significant milestone' UK-based SkyePharma has been given a boost in regards to its asthma treatment following the release of positive Phase III results... Read FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants... Read Japan's Tamiflu supply halved Japan will only be receiving 50 per cent of its usual supply of the blockbuster flu drug Tamiflu (oseltamivir) this year, thanks to significantly reduced demand following reports of suicidal behaviour in adolescents... Read Neural stem cell drug delivery is encapsulating Inherited genetic disorders could be treated with a new stem cell-based drug delivery therapy through the use of microcapsules... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines Gene Logic drops genomics and name for drug repositioning After selling of its genomics business to Ocimum Biosolutions, Gene Logic is to change its name to Ore Pharmaceuticals as it looks to mine out new indications for drugs... Read GSK blocks new patent rules Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read Nikon halves imaging time with new integrated microscope Nikon has launched a new inverted microscope range that promises to more than half the time of an imaging experiment while enabling more simultaneous applications... Read Cells caught in a 'tractor beam' US researchers have developed a 'tractor beam' that that can pick up, hold and move individual cells around a microchip surface - paving the way for more sensitive biological devices... Read Treating cancer as infectious disease yields results For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com